Post-operative hearing among patients with labyrinthine fistula as a complication of cholesteatoma using "under water technique".


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 18 03 2021
accepted: 23 08 2021
pubmed: 21 9 2021
medline: 27 5 2022
entrez: 20 9 2021
Statut: ppublish

Résumé

During surgery in patients with labyrinthine fistula the mandatory complete removal of the cholesteatoma while preserving inner ear and vestibular function is a challenge. Options so far have been either the complete removal of the cholesteatoma or leaving the matrix on the fistula. We evaluated an alternative "under water" surgical technique for complete cholesteatoma resection, in terms of preservation of postoperative inner ear and vestibular function. From 2013 to 2019, 20 patients with labyrinthine fistula due to cholesteatoma were operated. We used the canal wall down approach and removal of matrix on the fistula was done as the last step during surgery using the "under water technique". The pre and postoperative hearing tests and the vestibular function were retrospectively examined. There was no significant difference between pre and post-operative bone conduction thresholds; 20% experienced an improvement of more than 10 dB, with none experiencing a postoperative worsening of sensorineural hearing loss. Among seven patients who presented with vertigo, two had transient vertigo postoperatively but eventually recovered. Our data show that the "under water technique" for cholesteatoma removal at the labyrinthine fistula is a viable option in the preservation of inner ear function and facilitating complete cholesteatoma removal.

Identifiants

pubmed: 34541608
doi: 10.1007/s00405-021-07058-z
pii: 10.1007/s00405-021-07058-z
pmc: PMC9130190
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3355-3362

Informations de copyright

© 2021. The Author(s).

Références

Otolaryngol Head Neck Surg. 1991 Jan;104(1):110-5
pubmed: 1706085
HNO. 1959 Aug 31;7:349-50
pubmed: 13840536
Otol Neurotol. 2015 Sep;36(8):1297-300
pubmed: 26154844
Arch Otolaryngol Head Neck Surg. 1986 Sep;112(9):982-5
pubmed: 3741667
J Laryngol Otol. 2019 Dec;133(12):1074-1078
pubmed: 31735175
Indian J Otolaryngol Head Neck Surg. 2017 Jun;69(2):204-209
pubmed: 28607891
Otolaryngol Head Neck Surg. 2009 Mar;140(3):406-11
pubmed: 19248953
Otolaryngol Head Neck Surg. 1995 Mar;112(3):410-4
pubmed: 7870441
Am J Otol. 1997 Nov;18(6):697-701
pubmed: 9391663
Ann Otol Rhinol Laryngol. 2017 Mar;126(3):205-215
pubmed: 28071070
Ann Otol Rhinol Laryngol Suppl. 1984 Jul-Aug;112:138-41
pubmed: 6431874
Otolaryngol Head Neck Surg. 2019 Aug;161(1_suppl):S1-S45
pubmed: 31369359
Braz J Otorhinolaryngol. 2019 Mar - Apr;85(2):222-227
pubmed: 29599061
HNO. 2003 Apr;51(4):310-4
pubmed: 12682733
Am J Otol. 1988 Nov;9(6):470-5
pubmed: 3232718
Laryngoscope. 1970 Jul;80(7):1025-35
pubmed: 5450297
Otol Neurotol. 2014 Jul;35(6):981-8
pubmed: 24936778
Am J Otol. 1996 May;17(3):410-5
pubmed: 8817018
Acta Otorhinolaryngol Belg. 1997;51(2):119-21
pubmed: 9241379
Eur Arch Otorhinolaryngol. 2016 Aug;273(8):2055-63
pubmed: 26351038
Ann Otol Rhinol Laryngol. 2013 Aug;122(8):529-34
pubmed: 24027864
Am J Otol. 2000 Jan;21(1):32-5
pubmed: 10651432
HNO. 2015 Jun;63(6):396-401
pubmed: 25008276
Clin Otolaryngol Allied Sci. 1978 Aug;3(3):315-21
pubmed: 737867
Eur Arch Otorhinolaryngol. 2012 Apr;269(4):1085-90
pubmed: 21915756
J Laryngol Otol. 2010 Jun;124(6):587-93
pubmed: 20156369
Laryngoscope. 2016 Apr;126(4):980-7
pubmed: 26404516
Acta Otolaryngol. 2011 Jun;131(6):572-8
pubmed: 21189049
Laryngoscope. 2014 Nov;124(11):2616-8
pubmed: 24932655
Eur Arch Otorhinolaryngol. 2017 Oct;274(10):3605-3612
pubmed: 28799140
Otolaryngol Head Neck Surg. 2000 May;122(5):739-42
pubmed: 10793357
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):628-32
pubmed: 19128667
Ann Otolaryngol Chir Cervicofac. 2001 Jun;118(3):181-6
pubmed: 11431592
Laryngoscope. 1979 Jan;89(1):78-87
pubmed: 423655
Iran J Otorhinolaryngol. 2019 May;31(104):167-172
pubmed: 31223596
Ann Otol Rhinol Laryngol. 2012 Mar;121(3):162-7
pubmed: 22530475
ORL J Otorhinolaryngol Relat Spec. 1984;46(3):165-72
pubmed: 6728439

Auteurs

K Thangavelu (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Klinik Für HNO-Heilkunde, University Hospital Marburg, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany. Kruthika.thangavelu@uk-gm.de.

R Weiß (R)

Department of Otorhinolaryngology, Head and Neck Surgery, Klinik Für HNO-Heilkunde, University Hospital Marburg, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany.

J Mueller-Mazzotta (J)

Department of Otorhinolaryngology, Head and Neck Surgery, Klinik Für HNO-Heilkunde, University Hospital Marburg, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany.

M Schulze (M)

Department of Neuroradiology, University Hospital Marburg, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany.

B A Stuck (BA)

Department of Otorhinolaryngology, Head and Neck Surgery, Klinik Für HNO-Heilkunde, University Hospital Marburg, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany.

K Reimann (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Klinik Für HNO-Heilkunde, University Hospital Marburg, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH